Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BMED declined for three days, in 216 of 279 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on BMED as a result. In 69 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for BMED just turned positive on October 15, 2026. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 226 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
XBI moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend. In 45 of 50 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XBI as a result. In 73 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The 10-day moving average for XBI crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XBI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for XBI entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +0.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where XBI advanced for three days, in 297 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
XBI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
| BMED | XBI | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 73% | N/A |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 90% |
| Advances ODDS (%) | 3 days ago 81% | 18 days ago 90% |
| Declines ODDS (%) | 5 days ago 77% | 4 days ago 89% |
| BollingerBands ODDS (%) | N/A | 2 days ago 89% |
| Aroon ODDS (%) | N/A | 2 days ago 90% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| STOT | 46.31 | 0.03 | +0.05% |
| State Street DoubleLine Short Duration Total Return Tactical ETF (STOT) | |||
| CPSD | 27.23 | N/A | N/A |
| Calamos S&P 500 Structured Alt Protection ETF - December (CPSD) | |||
| ENDW | 34.53 | -0.07 | -0.21% |
| Cambria Endowment Style ETF (ENDW) | |||
| MCDS | 66.09 | -0.52 | -0.78% |
| JPMorgan Fundamental Data Science Mid Core ETF (MCDS) | |||
| AAXJ | 108.12 | -2.24 | -2.03% |
| iShares MSCI All Country Asia ex Japan ETF (AAXJ) | |||
A.I.dvisor tells us that BMED and BRKR have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMED and BRKR's prices will move in lockstep.
| Ticker / NAME | Correlation To BMED | 1D Price Change % | ||
|---|---|---|---|---|
| BMED | 100% | -1.45% | ||
| BRKR - BMED | 19% Poorly correlated | -3.08% | ||
| MCRB - BMED | 13% Poorly correlated | -2.77% | ||
| ILMN - BMED | 13% Poorly correlated | -2.01% | ||
| BDX - BMED | 12% Poorly correlated | -1.04% | ||
| CNMD - BMED | 11% Poorly correlated | -0.89% | ||
More | ||||
A.I.dvisor indicates that over the last year, XBI has been loosely correlated with RCUS. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if XBI jumps, then RCUS could also see price increases.
| Ticker / NAME | Correlation To XBI | 1D Price Change % | ||
|---|---|---|---|---|
| XBI | 100% | -3.65% | ||
| RCUS - XBI | 60% Loosely correlated | -3.07% | ||
| VYGR - XBI | 59% Loosely correlated | -7.77% | ||
| LYEL - XBI | 57% Loosely correlated | -0.85% | ||
| LGND - XBI | 56% Loosely correlated | -0.99% | ||
| MGNX - XBI | 55% Loosely correlated | -3.56% | ||
More | ||||